Tag: #Global Trends

Strategic partnership for advanced biomanufacturing Transcenta Therapeutics and EirGenix Inc. have entered into a strategic non-exclusive licensing agreement, granting EirGenix... Read more

A pivotal step toward Phase 1 clinical trials Akari Therapeutics has officially launched GMP (Good Manufacturing Practice) activities for its... Read more

Legal battle over federal grants for child health The American Academy of Pediatrics (AAP) has filed a lawsuit against the... Read more

The European Commission has officially granted marketing authorization for Wayrilz (rilzabrutinib), a pioneering oral therapy for adults with immune thrombocytopenia... Read more

Pinnacle Blooms Network, the pediatric therapy division of Bharath Healthcare Laboratories, has secured a $70 million Series A investment proposal... Read more

In a move to strengthen its oncology pipeline, pharmaceutical giant Gilead Sciences has entered into an agreement to acquire RP-3467,... Read more

The U.S. Food and Drug Administration (FDA) has officially approved Yartemlea (narsoplimab), marking a historic milestone for the 31-year-old biotech... Read more

Large-scale biologics infrastructure project in Ahmedabad Kashiv BioSciences has secured 648 crore INR (approximately $77 million) in financing from the... Read more

Next-generation electrical pulse therapy Abbott has officially received approval from the U.S. Food and Drug Administration (FDA) for its Volt™... Read more